These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 24598235)

  • 1. Angiogenesis, inflammation and endothelial function in postmenopausal women screened for the metabolic syndrome.
    Chedraui P; Escobar GS; Pérez-López FR; Palla G; Montt-Guevara M; Cecchi E; Genazzani AR; Simoncini T;
    Maturitas; 2014 Apr; 77(4):370-4. PubMed ID: 24598235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitric oxide and pro-inflammatory cytokine serum levels in postmenopausal women with the metabolic syndrome.
    Chedraui P; Escobar GS; Ramírez C; Pérez-López FR; Hidalgo L; Mannella P; Genazzani A; Simoncini T
    Gynecol Endocrinol; 2012 Oct; 28(10):787-91. PubMed ID: 22468900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pro-inflammatory cytokine levels in postmenopausal women with the metabolic syndrome.
    Chedraui P; Jaramillo W; Pérez-López FR; Escobar GS; Morocho N; Hidalgo L
    Gynecol Endocrinol; 2011 Sep; 27(9):685-91. PubMed ID: 20937002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The metabolic syndrome and its components in postmenopausal women.
    Chedraui P; San Miguel G; Vintimilla-Sigüenza I; Villacreses D; Romero-Huete L; Domínguez A; Jaramillo W; Escobar GS; Pérez-López FR; Genazzani AR; Simoncini T;
    Gynecol Endocrinol; 2013 Jun; 29(6):563-8. PubMed ID: 23656385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphisms of the FTO and MTHFR genes and vascular, inflammatory and metabolic marker levels in postmenopausal women.
    Chedraui P; Pérez-López FR; Escobar GS; Espinoza-Caicedo JA; Montt-Guevara M; Genazzani AR; Simoncini T;
    J Endocrinol Invest; 2016 Aug; 39(8):885-90. PubMed ID: 26902996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Omega-3 PUFAs improved endothelial function and arterial stiffness with a parallel antiinflammatory effect in adults with metabolic syndrome.
    Tousoulis D; Plastiras A; Siasos G; Oikonomou E; Verveniotis A; Kokkou E; Maniatis K; Gouliopoulos N; Miliou A; Paraskevopoulos T; Stefanadis C
    Atherosclerosis; 2014 Jan; 232(1):10-6. PubMed ID: 24401211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative effects of carbohydrate versus fat restriction on serum levels of adipocytokines, markers of inflammation, and endothelial function among women with the metabolic syndrome: a randomized cross-over clinical trial.
    Rajaie S; Azadbakht L; Saneei P; Khazaei M; Esmaillzadeh A
    Ann Nutr Metab; 2013; 63(1-2):159-67. PubMed ID: 24021709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the presence and severity of menopausal symptoms among postmenopausal women screened for the metabolic syndrome.
    Chedraui P; Pérez-López FR; Hidalgo L; Villacreses D; Domínguez A; Escobar GS; Genazzani AR; Simoncini T;
    Gynecol Endocrinol; 2014; 30(12):918-24. PubMed ID: 25347000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of insomnia and related risk factors in postmenopausal women screened for the metabolic syndrome.
    Chedraui P; San Miguel G; Villacreses D; Dominguez A; Jaramillo W; Escobar GS; Pérez-López FR; Genazzani AR; Simoncini T;
    Maturitas; 2013 Feb; 74(2):154-9. PubMed ID: 23176759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of a moderate-intensity walking program on cardiometabolic risk markers in overweight to obese women: is there any influence of menopause?
    Riesco E; Tessier S; Lacaille M; Pérusse F; Côté M; Després JP; Bergeron J; Weisnagel JS; Doré J; Mauriège P
    Menopause; 2013 Feb; 20(2):185-93. PubMed ID: 23096247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Components of the interleukin-6 transsignalling system are associated with the metabolic syndrome, endothelial dysfunction and arterial stiffness.
    Weiss TW; Arnesen H; Seljeflot I
    Metabolism; 2013 Jul; 62(7):1008-13. PubMed ID: 23428306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risks of CHD identified by different criteria of metabolic syndrome and related changes of adipocytokines in elderly postmenopausal women.
    Ding QF; Hayashi T; Zhang XJ; Funami J; Ge L; Li J; Huang XL; Cao L; Zhang J; Akihisa I
    J Diabetes Complications; 2007; 21(5):315-9. PubMed ID: 17825756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasminogen activator inhibitor-1 as a measure of vascular remodelling in breast cancer.
    Fox SB; Taylor M; Grøndahl-Hansen J; Kakolyris S; Gatter KC; Harris AL
    J Pathol; 2001 Sep; 195(2):236-43. PubMed ID: 11592104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic syndrome and its associated risk factors in Brazilian postmenopausal women.
    Petri Nahas EA; Padoani NP; Nahas-Neto J; Orsatti FL; Tardivo AP; Dias R
    Climacteric; 2009 Oct; 12(5):431-8. PubMed ID: 19415539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relation of high-sensitivity C-reactive protein, interleukin-6, tumor necrosis factor-alpha, and fibrinogen to abdominal adipose tissue, blood pressure, and cholesterol and triglyceride levels in healthy postmenopausal women.
    Piché ME; Lemieux S; Weisnagel SJ; Corneau L; Nadeau A; Bergeron J
    Am J Cardiol; 2005 Jul; 96(1):92-7. PubMed ID: 15979442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex hormone binding globulin gene polymorphisms and metabolic syndrome in postmenopausal Turkish women.
    Sunbul M; Eren F; Nacar C; Agirbasli M
    Cardiol J; 2013; 20(3):287-93. PubMed ID: 23788303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High levels of urokinase-type plasminogen activator and its inhibitor PAI-1 in cytosolic extracts of breast carcinomas are associated with poor prognosis.
    Grøndahl-Hansen J; Christensen IJ; Rosenquist C; Brünner N; Mouridsen HT; Danø K; Blichert-Toft M
    Cancer Res; 1993 Jun; 53(11):2513-21. PubMed ID: 8388317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble CD40 ligand, soluble P-selectin and von Willebrand factor levels in subjects with prediabetes: the impact of metabolic syndrome.
    Genc H; Dogru T; Tapan S; Tasci I; Bozoglu E; Gok M; Aslan F; Celebi G; Erdem G; Avcu F; Ural AU; Sonmez A
    Clin Biochem; 2012 Jan; 45(1-2):92-5. PubMed ID: 22100896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High prevalence of metabolic syndrome in Takayasu arteritis: increased cardiovascular risk and lower adiponectin serum levels.
    da Silva TF; Levy-Neto M; Bonfá E; Pereira RM
    J Rheumatol; 2013 Nov; 40(11):1897-904. PubMed ID: 24037555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of a lifestyle program on vascular insulin resistance in metabolic syndrome subjects: the RESOLVE study.
    Vinet A; Obert P; Dutheil F; Diagne L; Chapier R; Lesourd B; Courteix D; Walther G
    J Clin Endocrinol Metab; 2015 Feb; 100(2):442-50. PubMed ID: 25353072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.